TipRanks
Fresenius Medical Care AG & Co. KGaA (CH:FME)
:FME
Switzerland Market
FME
Fresenius Medical Care AG & Co. KGaA
RESEARCH TOOLSreports

Fresenius Medical Care AG & Co. KGaA (FME) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

FME Analyst Ratings

Moderate Sell
12Ratings
Moderate Sell
1 Buy
6 Hold
5 Sell
Based on 12 analysts giving stock ratings to
Fresenius
Medical Care AG & Co. KGaA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

FME Stock 12 Month Forecast

Average Price Target

CHF34.81
▼(-4.04% Downside)
Based on 12 Wall Street analysts offering 12 month price targets for Fresenius Medical Care AG & Co. KGaA in the last 3 months. The average price target is CHF34.81 with a high forecast of CHF41.56 and a low forecast of CHF27.92. The average price target represents a -4.04% change from the last price of CHF36.28.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"26":"CHF26","77":"CHF77","38.75":"CHF38.8","51.5":"CHF51.5","64.25":"CHF64.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":41.558040187,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF41.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34.81432481918182,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF34.81</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27.9225354,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF27.92</span>\n  </div></div>","useHTML":true}}],"tickPositions":[26,38.75,51.5,64.25,77],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.35,37.673695399,37.997390798000005,38.321086197,38.644781596,38.968476995,39.292172394000005,39.615867793,39.939563192,40.263258591,40.586953990000005,40.910649389,41.234344788,{"y":41.558040187,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.35,37.15494806301399,36.95989612602797,36.76484418904196,36.56979225205595,36.37474031506993,36.17968837808392,35.984636441097905,35.78958450411189,35.594532567125874,35.39948063013986,35.20442869315385,35.00937675616783,{"y":34.81432481918182,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.35,36.624810415384616,35.89962083076923,35.174431246153844,34.449241661538466,33.72405207692308,32.998862492307694,32.27367290769231,31.548483323076923,30.82329373846154,30.098104153846155,29.372914569230772,28.647724984615387,{"y":27.9225354,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":76.681,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":76.681,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":76.681,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":37.082,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":33.536,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":34.487,"date":1772323200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":33.776,"date":1775001600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":34.737,"date":1777593600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":34.76,"date":1780272000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":37.32,"date":1782864000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 17</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":40.38,"date":1785542400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":37.85,"date":1788220800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 12</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":37.35,"date":1790812800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF41.56Average Price TargetCHF34.81Lowest Price TargetCHF27.92
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Deutsche Bank Analyst forecast on CH:FME
Falko Friedrichs
Deutsche Bank
Deutsche Bank
CHF37.23
Hold
2.62%
Upside
Reiterated
10/09/26
Deutsche Bank Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Bernstein Analyst forecast on CH:FME
Susannah Ludwig
Bernstein
Bernstein
CHF41.56
Hold
14.55%
Upside
Reiterated
10/08/26
Bernstein Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Bank of America Securities Analyst forecast on CH:FME
Anna Ractliffe
Bank of America Securities
Bank of America Securities
CHF29.78
Sell
-17.91%
Downside
Reiterated
10/07/26
Analyst Reiterates Sell on Fresenius Medical Care, Keeps $32 Price Target Amid Ongoing Operational and Leadership Risks
J.P. Morgan Analyst forecast on CH:FME
David Adlington
J.P. Morgan
J.P. Morgan
CHF30.06
Sell
-17.14%
Downside
Reiterated
10/07/26
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from J.P. Morgan
Goldman Sachs Analyst forecast on CH:FME
Richard Felton
Goldman Sachs
Goldman Sachs
CHF36.3→CHF35.37
Hold
-2.51%
Downside
Reiterated
09/30/26
Goldman Sachs Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Berenberg Bank Analyst forecast on CH:FME
Harry Gillis
Berenberg Bank
Berenberg Bank
CHF55.85→CHF39.09
Hold
7.75%
Upside
Downgraded
09/29/26
Berenberg Bank downgrades Fresenius Medical Care AG & Co. KGaA (0H9X) to a Hold
Jefferies Analyst forecast on CH:FME
James Vane
Jefferies
Jefferies
CHF28.85→CHF27.92
Sell
-23.04%
Downside
Reiterated
08/11/26
Jefferies Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
DZ BANK AG Analyst forecast on CH:FME
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
―
Buy
―
Reiterated
08/06/26
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Buy from DZ BANK AG
Barclays Analyst forecast on CH:FME
Hassan Al-Wakeel
Barclays
Barclays
CHF42.81→CHF41.42
Hold
14.16%
Upside
Reiterated
08/06/26
Barclays Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Morgan Stanley Analyst forecast on CH:FME
Aisyah Noor
Morgan Stanley
Morgan Stanley
CHF29.78→CHF28.85
Sell
-20.47%
Downside
Reiterated
08/05/26
Fresenius Medical price target lowered to EUR 31 from EUR 32 at Morgan StanleyFresenius Medical price target lowered to EUR 31 from EUR 32 at Morgan Stanley
UBS Analyst forecast on CH:FME
Graham Doyle
UBS
UBS
CHF34.44→CHF33.51
Sell
-7.64%
Downside
Reiterated
08/04/26
UBS Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Citi Analyst forecast on CH:FME
Veronika Dubajova
Citi
Citi
CHF37.23→CHF38.16
Hold
5.18%
Upside
Reiterated
07/17/26
Fresenius Medical price target raised to EUR 41 from EUR 40 at CitiFresenius Medical price target raised to EUR 41 from EUR 40 at Citi
Kepler Capital Analyst forecast on CH:FME
Oliver Reinberg
Kepler Capital
Kepler Capital
CHF40.02
Hold
10.32%
Upside
Reiterated
05/05/26
Kepler Capital Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
mwb research Analyst forecast on CH:FME
Harald Hof
mwb research
mwb research
CHF42.81→CHF43.75
Buy
20.58%
Upside
Upgraded
01/12/26
Wolfe Research Analyst forecast on CH:FME
Robert Davies
Wolfe Research
Wolfe Research
CHF42.81→CHF38.16
Sell
5.18%
Upside
Reiterated
10/14/25
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from Morgan Stanley
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Deutsche Bank Analyst forecast on CH:FME
Falko Friedrichs
Deutsche Bank
Deutsche Bank
CHF37.23
Hold
2.62%
Upside
Reiterated
10/09/26
Deutsche Bank Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Bernstein Analyst forecast on CH:FME
Susannah Ludwig
Bernstein
Bernstein
CHF41.56
Hold
14.55%
Upside
Reiterated
10/08/26
Bernstein Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Bank of America Securities Analyst forecast on CH:FME
Anna Ractliffe
Bank of America Securities
Bank of America Securities
CHF29.78
Sell
-17.91%
Downside
Reiterated
10/07/26
Analyst Reiterates Sell on Fresenius Medical Care, Keeps $32 Price Target Amid Ongoing Operational and Leadership Risks
J.P. Morgan Analyst forecast on CH:FME
David Adlington
J.P. Morgan
J.P. Morgan
CHF30.06
Sell
-17.14%
Downside
Reiterated
10/07/26
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from J.P. Morgan
Goldman Sachs Analyst forecast on CH:FME
Richard Felton
Goldman Sachs
Goldman Sachs
CHF36.3→CHF35.37
Hold
-2.51%
Downside
Reiterated
09/30/26
Goldman Sachs Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Berenberg Bank Analyst forecast on CH:FME
Harry Gillis
Berenberg Bank
Berenberg Bank
CHF55.85→CHF39.09
Hold
7.75%
Upside
Downgraded
09/29/26
Berenberg Bank downgrades Fresenius Medical Care AG & Co. KGaA (0H9X) to a Hold
Jefferies Analyst forecast on CH:FME
James Vane
Jefferies
Jefferies
CHF28.85→CHF27.92
Sell
-23.04%
Downside
Reiterated
08/11/26
Jefferies Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
DZ BANK AG Analyst forecast on CH:FME
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
―
Buy
―
Reiterated
08/06/26
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Buy from DZ BANK AG
Barclays Analyst forecast on CH:FME
Hassan Al-Wakeel
Barclays
Barclays
CHF42.81→CHF41.42
Hold
14.16%
Upside
Reiterated
08/06/26
Barclays Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Morgan Stanley Analyst forecast on CH:FME
Aisyah Noor
Morgan Stanley
Morgan Stanley
CHF29.78→CHF28.85
Sell
-20.47%
Downside
Reiterated
08/05/26
Fresenius Medical price target lowered to EUR 31 from EUR 32 at Morgan StanleyFresenius Medical price target lowered to EUR 31 from EUR 32 at Morgan Stanley
UBS Analyst forecast on CH:FME
Graham Doyle
UBS
UBS
CHF34.44→CHF33.51
Sell
-7.64%
Downside
Reiterated
08/04/26
UBS Sticks to Their Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Citi Analyst forecast on CH:FME
Veronika Dubajova
Citi
Citi
CHF37.23→CHF38.16
Hold
5.18%
Upside
Reiterated
07/17/26
Fresenius Medical price target raised to EUR 41 from EUR 40 at CitiFresenius Medical price target raised to EUR 41 from EUR 40 at Citi
Kepler Capital Analyst forecast on CH:FME
Oliver Reinberg
Kepler Capital
Kepler Capital
CHF40.02
Hold
10.32%
Upside
Reiterated
05/05/26
Kepler Capital Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
mwb research Analyst forecast on CH:FME
Harald Hof
mwb research
mwb research
CHF42.81→CHF43.75
Buy
20.58%
Upside
Upgraded
01/12/26
Wolfe Research Analyst forecast on CH:FME
Robert Davies
Wolfe Research
Wolfe Research
CHF42.81→CHF38.16
Sell
5.18%
Upside
Reiterated
10/14/25
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from Morgan Stanley
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Fresenius Medical Care AG & Co. KGaA

3 Months
James VaneJefferies
Success Rate
24/52 ratings generated profit
46%
Average Return
-2.77%
Copying James Vane's trades and holding each position for 3 Months would result in 46.15% of your transactions generating a profit, with an average return of -2.77% per trade.
1 Year
David AdlingtonJ.P. Morgan
Success Rate
39/69 ratings generated profit
57%
Average Return
+1.58%
Copying David Adlington's trades and holding each position for 1 Year would result in 56.52% of your transactions generating a profit, with an average return of +1.58% per trade.
2 Years
James VaneJefferies
Success Rate
28/52 ratings generated profit
54%
Average Return
-3.47%
Copying James Vane's trades and holding each position for 2 Years would result in 53.85% of your transactions generating a profit, with an average return of -3.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

FME Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
1
1
1
1
1
Hold
8
8
8
9
8
Sell
13
17
16
12
9
Strong Sell
0
0
0
0
0
total
22
26
25
22
18
In the current month, FME has received 1 Buy Ratings, 8 Hold Ratings, and 9 Sell Ratings. FME average Analyst price target in the past 3 months is 34.81.
Each month's total comprises the sum of three months' worth of ratings.

FME Financial Forecast

FME Earnings Forecast

Next quarter’s earnings estimate for FME is CHF0.99 with a range of CHF0.85 to CHF1.13. The previous quarter’s EPS was CHF1.04. FME beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year FME has Performed in-line its overall industry.
Next quarter’s earnings estimate for FME is CHF0.99 with a range of CHF0.85 to CHF1.13. The previous quarter’s EPS was CHF1.04. FME beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year FME has Performed in-line its overall industry.

FME Sales Forecast

Next quarter’s sales forecast for FME is CHF4.57B with a range of CHF4.50B to CHF4.67B. The previous quarter’s sales results were CHF4.52B. FME beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year FME has Performed in-line its overall industry.
Next quarter’s sales forecast for FME is CHF4.57B with a range of CHF4.50B to CHF4.67B. The previous quarter’s sales results were CHF4.52B. FME beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year FME has Performed in-line its overall industry.

FME Stock Forecast FAQ

What is CH:FME’s average 12-month price target, according to analysts?
Based on analyst ratings, Fresenius Medical Care AG & Co. KGaA’s 12-month average price target is 34.81.
    What is CH:FME’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:FME, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Fresenius Medical Care AG & Co. KGaA a Buy, Sell or Hold?
        Fresenius Medical Care AG & Co. KGaA has a consensus rating of Moderate Sell, which is based on 1 buy ratings, 6 hold ratings and 5 sell ratings.
          What is Fresenius Medical Care AG & Co. KGaA’s share price target?
          The average share price target for Fresenius Medical Care AG & Co. KGaA is 34.81. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF41.56 ,and the lowest forecast is CHF27.92. The average share price target represents -4.04% Decrease from the current price of CHF36.28.
            What do analysts say about Fresenius Medical Care AG & Co. KGaA?
            Fresenius Medical Care AG & Co. KGaA’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 12 Wall Streets Analysts.
              How can I buy shares of Fresenius Medical Care AG & Co. KGaA?
              To buy shares of CH:FME, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.